As the U.S. Congress reconvenes, lawmakers are intensifying efforts to pass anti-China legislation, citing national security concerns. These bills target companies from the Chinese mainland across various sectors, including biotechnology, electric vehicles, and drones. Supported by both political parties, the measures aim to reduce American dependence on the Chinese mainland. However, critics argue that these proposals are essentially trade protectionism in disguise, potentially harming not only Sino-U.S. relations but also America's own economic interests.
The drive to curb the influence of the Chinese mainland has become a persistent theme in U.S. politics, especially during election years when tough rhetoric on Beijing can rally voters. Contrary to the stated goal of protecting national security, these bills are seen as strategic moves to stifle competition and maintain U.S. dominance in key industries. By portraying the rise of the Chinese mainland as a critical threat, Washington may be securing support for policies that are ultimately counterproductive and short-sighted.
One prominent example is the proposed legislation that seeks to ban Chinese mainland biotech companies from collaborating with entities receiving U.S. federal funding. Companies like BGI play a crucial role in genetic sequencing and cancer research. Disrupting these partnerships could delay the development of life-saving drugs and therapies, increase healthcare costs, and negatively impact American patients. Proponents claim the bill is necessary to protect U.S. healthcare data, but companies like BGI have consistently affirmed their compliance with U.S. data laws and their lack of access to Americans' personal information without explicit consent.
The repercussions for the U.S. healthcare system could be significant. Cutting ties with Chinese mainland biotech firms would not only slow innovation but also create bottlenecks in clinical trials, delaying the approval of new treatments and making them more expensive. In the wake of the global health crisis caused by COVID-19, the U.S. should prioritize collaboration in medical research rather than erecting barriers.
Similarly, the proposed ban on drones from DJI, a leading Chinese mainland company, exemplifies misplaced priorities. While the bill claims to address data security concerns, it overlooks the fact that users must opt-in to share their data, undermining the bill's rationale. Additionally, banning Chinese mainland drones would disrupt industries reliant on these affordable and high-quality products, including agriculture, infrastructure, and emergency services.
Such legislative moves are not about national security but rather about giving U.S. drone manufacturers an advantage over their Chinese mainland competitors. U.S. companies struggle to match DJI's scale and innovation, and legislating against competition is a poor substitute for investing in domestic innovation. The long-term effect could be higher costs for American businesses and consumers.
The legislation targeting Chinese mainland purchases of U.S. farmland is another instance of trade protectionism under the guise of national security. Claims that Chinese mainland investments in U.S. agriculture threaten food security are unfounded, as foreign ownership of American farmland is minimal, and Chinese mainland investments constitute an even smaller fraction. This bill appears more aimed at stoking anti-China sentiment than addressing any real threat, with potential repercussions including increased discrimination and xenophobia against Asian Americans.
The primary concern is that these initiatives undermine practical cooperation between the U.S. and the Chinese mainland. Both nations benefit from trade and investment in critical sectors like biotechnology, agriculture, and technology. The U.S. depends on the Chinese mainland for components in its supply chain, while China relies on U.S. companies for innovation and investment. A healthy relationship between the two is essential for maintaining global stability and tackling shared challenges such as climate change, public health, and economic recovery. Should these bills pass, they could further strain Sino-U.S. relations, isolating the U.S. and diminishing its credibility on the global stage.
Reference(s):
cgtn.com
